nderstanding the role of 1.5% levofloxacin drops in eyes with bacterial keratitis
Phase 4
- Conditions
- Health Condition 1: H168- Other keratitis
- Registration Number
- CTRI/2020/06/025981
- Lead Sponsor
- Santen India Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Microbiologically proven bacterial keratitis
2. Size of ulcer ranging between 2-8mm
3. Patients willing to participate and follow up
Exclusion Criteria
a) Patients with age less than 18 years
b) Mixed infections; concomitant fungal, viral or acanthamoeba infections
c) Size of ulcer less than 2mm and more than 8 mm
d) Impending perforation or presence of corneal perforation at the time of presentation
e) Associated endophthalmitis
f) Pregnant and lactating females
g) Patient not willing to participate and follow up
h) Patients with known allergy to fluoroquinolones, aminoglycosides and cephalosporins
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method